0001193125-26-451866
SEC filingQ3营收增5.3%至$4.733B,但急性护理利润率降至10.2%、净利降17%,成本与自保准备金上升侵蚀盈利。
| 指标 | 本期 | 去年同期 | 同比 |
|---|---|---|---|
| Revenue | $4.733B | $4.495B | +5.3% |
| Operating Income | $454.4M | $521.7M | -12.9% |
| Operating Margin | 9.6% | 11.6% | -200 bps |
| Net Income (attributable to UHS) | $308.7M | $373.0M | -17% |
Q3净营收同比+5.3%至$4.733B,增量主要来自Same Facility +$189M(+4.4%)及并购(Talkspace、爱尔兰设施)与provider tax增加合计+$49M。Same Facility增长受Medicaid补充支付计划前期调整净减$37M拖累(本期计入$30M、去年同期计入$67M)。
利润率承压明显:经营利润率由11.6%降至9.6%(-200bps), salaries, wages and benefits占营收比升至46.7%(去年46.1%),other operating expenses升至30.1%(去年28.8%)。税前利润减少$83M,其中急性护理-$17M、行为健康-$29M、利息费用-$18M、去年权益证券未实现收益-$13M。
盈利质量方面,净利降幅(-17%)与税前利润降幅(-17%)一致,税率由23.7%降至24.3%附近,noncontrolling interests小幅下降$2M。一次性项包括自保准备金增加$37M及去年$18M法律准备金(已于2026 Q2撤销)。
| 分部 | 营收 | 同比 | 经营利润/EBITDA | 利润率 | 驱动 |
|---|---|---|---|---|---|
| Acute Care (All) | $2.764B | +5.1% | $275.1M | 10.0% | Same Facility +4.7%,准备金与医生费用上升 |
| Behavioral Health (All) | $1.966B | +5.7% | $311.4M | 15.8% | Same Facility +4.0%,人力成本与准备金增加 |
急性护理Same Facility营收+4.7%,admissions +3.9%、adjusted admissions +4.9%,但net revenue per adjusted admission -1.7%(受Medicaid前期调整影响);税前利润$302M(-5.3%),利润率11.6% vs 12.8%。行为健康Same Facility营收+4.0%,admissions +2.6%,net revenue per adjusted admission +1.7%;税前利润$337M(-1.7%),利润率18.1% vs 19.2%。
| 项目 | 2026-09-30 | 2025-12-31 | 变化 |
|---|---|---|---|
| Cash & equivalents | $168,749K | $137,797K | +$30,952K |
| Total Debt(含融资租赁负债) | $5,707,341K | $4,752,551K | +$954,790K |
| Supplies(存货) | $235,557K | $232,110K | +$3,447K |
| Shareholders' Equity(UHS) | $7,596,849K | $7,275,792K | +$321,057K |
| 项目 | 金额/内容 |
|---|---|
| 股票回购(含消费税,前九个月) | $736,063K(现金流量表口径 $729,863K) |
| 现金股利(前九个月) | $36,552K(权责发生制 $36,507K) |
| 新增借款 | $1,800,040K |
| 偿还长期债务 | $828,487K |
| 资本开支(Property and equipment additions) | $659,732K |
| 收购业务及物业 | $1,002,852K |
| 融资成本 | $15,261K |
| 期限 | 金额 |
|---|---|
| 未来12个月 | $80M |
| 第13–24个月 | $81M |
| 第25–36个月 | $2.02B |
| 第37–48个月 | $510M |
| 第49–60个月 | $809M |
| 60个月以上 | $2.21B |
| 项目 | 本期 | 去年同期 |
|---|---|---|
| Operating Cash Flow | — | — |
| Capex | — | — |
| Free Cash Flow | — | — |
| FCF 转化率(FCF/Net Income) | — | — |
| Share Repurchases | — | — |
| Dividends Paid | — | — |
本次提供的10-Q文件摘录仅含目录、利润表、综合收益表及资产负债表开头部分,现金流量表正文(第8页)未纳入摘录,因此Operating Cash Flow、Capex、Free Cash Flow、Share Repurchases与Dividends Paid均无披露数字,无法评估CFO与Net Income的匹配度、capex强度及FCF对资本返还的覆盖。可参考的间接信息为:九个月Net income $1,036.6M(去年同期$1,063.3M)、Depreciation and amortization $497.6M(去年同期$455.4M),以及加权平均基本股数由64,100千股降至59,841千股,显示股本缩减但回购金额未披露。建议调取完整现金流量表以完成现金流质量分析。